Clinical Trial
doi: 10.1016/s0924-9338(02)00673-9.
Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment
Affiliations
- PMID: 12381502
- DOI: 10.1016/s0924-9338(02)00673-9
Item in Clipboard
Clinical Trial
Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment
Eur Psychiatry.
2002 Sep.
No abstract available
Similar articles
-
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.J Clin Psychiatry. 2001 Apr;62(4):297-8. doi: 10.4088/jcp.v62n0413e. J Clin Psychiatry. 2001. PMID: 11379848 No abstract available.
-
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.J Clin Psychiatry. 1999 Aug;60(8):524-7. doi: 10.4088/jcp.v60n0804. J Clin Psychiatry. 1999. PMID: 10485634 Clinical Trial.
-
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 2:II1-II14. doi: 10.1007/pl00014165. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10603070 No abstract available.
-
Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.Int Clin Psychopharmacol. 1998 Nov;13(6):253-62. Int Clin Psychopharmacol. 1998. PMID: 9861575 Review.
-
[Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].Fortschr Neurol Psychiatr. 2002 Apr;70(4):210-7. doi: 10.1055/s-2002-24644. Fortschr Neurol Psychiatr. 2002. PMID: 11948436 Review. German.
Cited by
-
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.NeuroRx. 2006 Jan;3(1):69-81. doi: 10.1016/j.nurx.2005.12.006. NeuroRx. 2006. PMID: 16490414 Free PMC article. Review.
-
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.Drugs R D. 2018 Sep;18(3):167-189. doi: 10.1007/s40268-018-0246-8. Drugs R D. 2018. PMID: 30171515 Free PMC article. Review.
-
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].BMC Psychiatry. 2005 Jan 24;5:5. doi: 10.1186/1471-244X-5-5. BMC Psychiatry. 2005. PMID: 15667657 Free PMC article. Clinical Trial.
-
Clinical treatment of obsessive compulsive disorder.Psychiatry (Edgmont). 2005 Nov;2(11):34-43. Psychiatry (Edgmont). 2005. PMID: 21120095 Free PMC article.
-
Childhood anxiety disorders and developmental issues in anxiety.Curr Psychiatry Rep. 2003 Aug;5(4):252-65. doi: 10.1007/s11920-003-0054-9. Curr Psychiatry Rep. 2003. PMID: 12857528 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
